Clinical trialNCT05691465RecruitingPhase 2Interventional

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

SponsorNational Cancer Institute (NCI)Enrollment35Metastatic Prostate Adenocarcinoma With Neuroendocrine DifferentiationMetastatic Prostate Neuroendocrine CarcinomaMetastatic Prostate Small Cell Neuroendocrine CarcinomaStage IVB Prostate Cancer AJCC v8

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

John M Floberg
JHU Sidney Kimmel Comprehensive Cancer Center LAO
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope Comprehensive Cancer Center
Duarte, California, United States
Abhishek Tripathi
Recruiting
Los Angeles General Medical Center
Los Angeles, California, United States
Jacek Pinski
Recruiting
Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
Jacek Pinski
Recruiting
University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
Active, not recruiting
Northwestern University
Chicago, Illinois, United States
Maha H. Hussain
Recruiting
University of Kentucky/markey Cancer Center
Lexington, Kentucky, United States
Zin W. Myint
Recruiting
Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
Michael A. Carducci
Recruiting
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Michael McCormack
Recruiting
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Edmund Folefac
Recruiting
Ut Southwestern/simmons Cancer Center-Dallas
Dallas, Texas, United States
Suspended
Ut Md Anderson Cancer Center
Houston, Texas, United States
Ana Aparicio
Recruiting
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
Madison, Wisconsin, United States
John M. Floberg
Recruiting
University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, United States
John M. Floberg
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 27 Dec 2023
Primary completion: 2 Nov 2026
Completion: 2 Nov 2026
Last update posted: 6 Jul 2026
Registered enrollment: 35
Registry id: NCT05691465

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.